{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:23:13Z","timestamp":1788996193892,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clbc.2025.05.013","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:16:09Z","timestamp":1747912569000},"page":"e1150-e1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tumor ki67 Impact on Survival in Male Breast Cancer Patients: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4714-6659","authenticated-orcid":false,"given":"Stephen","family":"Kinsey-Trotman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Swalling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallave","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy V.","family":"Ingman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clbc.2025.05.013_bib0001","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1016\/j.clbc.2021.01.013","article-title":"Gender disparity in breast cancer: a veteran population-based comparison","volume":"21","author":"Aggarwal","year":"2021","journal-title":"Clin Breast Cancer"},{"issue":"8","key":"10.1016\/j.clbc.2025.05.013_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136670","article-title":"A prognostic analysis of male breast cancer (MBC) compared with post-menopausal female breast cancer (FBC)","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.013_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-024-07446-z","article-title":"Influence of tumour grade on disease survival in male breast cancer patients: a systematic review","volume":"208","author":"Kinsey-Trotman","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2025.05.013_bib0004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(19910801)68:3<549::AID-CNCR2820680318>3.0.CO;2-J","article-title":"Ki67 immunostaining in node-negative stage I\/II breast carcinoma","volume":"68","author":"AA","year":"1991","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2025.05.013_bib0005","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1002\/1097-0142(19930615)71:12<3926::AID-CNCR2820711221>3.0.CO;2-2","article-title":"Proliferation index as a prognostic marker in breast cancer","volume":"71","author":"Veronese","year":"1993","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2025.05.013_bib0006","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2025.05.013_bib0007","first-page":"481","article-title":"Proliferative activity is a significant prognostic factor in male breast carcinoma","volume":"145","author":"Pich","year":"1994","journal-title":"American Journal of Pathology"},{"issue":"9","key":"10.1016\/j.clbc.2025.05.013_bib0008","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<1947::AID-CNCR10>3.0.CO;2-J","article-title":"Molecular markers in male breast carcinoma","volume":"83","author":"Rayson","year":"1998","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.013_bib0009","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/modpathol.2011.174","article-title":"Molecular subtyping of male breast cancer by immunohistochemistry","volume":"25","author":"Kornegoor","year":"2012","journal-title":"Modern Patholy"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.013_bib0010","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.breast.2013.08.008","article-title":"Therapeutic strategies in male breast cancer: clinical implications of chromosome 17 gene alterations and molecular subtypes","volume":"22","author":"Schildhaus","year":"2013","journal-title":"The Breast"},{"issue":"5","key":"10.1016\/j.clbc.2025.05.013_bib0011","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.clbc.2014.02.008","article-title":"Outcome of male breast cancer: a matched single-institution series","volume":"14","author":"Iorfida","year":"2014","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.013_bib0012","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4149\/neo_2014_043","article-title":"The biological markers and results of treatment in male breast cancer patients. The Cracow experience","volume":"61","author":"Sas-Korczynska","year":"2014","journal-title":"Neoplasma"},{"issue":"4","key":"10.1016\/j.clbc.2025.05.013_bib0013","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-14-0278","article-title":"Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment","volume":"171","author":"Wenhui","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.013_bib0014","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1634\/theoncologist.2014-0243","article-title":"Clinicopathological and immunohistochemical characteristics in male breast cancer: a retrospective case series","volume":"20","author":"Masci","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2025.05.013_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.breast.2015.12.001","article-title":"Male breast cancer: looking for better prognostic subgroups","volume":"26","author":"Abreu","year":"2016","journal-title":"Breast"},{"issue":"28","key":"10.1016\/j.clbc.2025.05.013_bib0016","doi-asserted-by":"crossref","first-page":"43188","DOI":"10.18632\/oncotarget.9668","article-title":"The Hippo transducers TAZ\/YAP and their target CTGF in male breast cancer","volume":"7","author":"Di Benedetto","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2025.05.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/srep45293","article-title":"Characterisation of male breast cancer: a descriptive biomarker study from a large patient series","volume":"7","author":"Humphries","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.clbc.2025.05.013_bib0018","first-page":"377","article-title":"Prognostic implications of the intrinsic molecular subtypes in male breast cancer","volume":"22","author":"Syrine","year":"2017","journal-title":"Journal of BUON"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.013_bib0019","first-page":"644","article-title":"Male breast cancer: specific biological characteristics and survival in a Portuguese cohort","volume":"10","author":"Andre","year":"2019","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.013_bib0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.21614\/chirurgia.115.3.323","article-title":"Analysis of clinical-pathological data with impact on overall survival in male breast carcinoma: an international multi-institutional study of 217 cases","volume":"115","author":"Boros","year":"2020","journal-title":"Chirurgia (Bucharest, Romania: 1990)"},{"issue":"2","key":"10.1016\/j.clbc.2025.05.013_bib0021","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/annonc\/mdx651","article-title":"Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2025.05.013_bib0022","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s12282-020-01066-3","article-title":"Male breast cancer: clinicopathological characterization of a national Danish cohort 1980-2009","volume":"27","author":"Jylling","year":"2020","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.013_bib0023","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/tbj.14120","article-title":"Characteristics and prognosis of male breast cancer in Brazil: a cohort study","volume":"27","author":"Thuler","year":"2021","journal-title":"Breast J"},{"issue":"11","key":"10.1016\/j.clbc.2025.05.013_bib0024","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.3390\/curroncol30110716","article-title":"Clinical, pathological, and prognostic features of male breast cancer: a multicenter study","volume":"30","author":"Accomasso","year":"2023","journal-title":"Current Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.013_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910310104","article-title":"Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation","volume":"31","author":"Gerdes","year":"1983","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.clbc.2025.05.013_bib0026","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.1711680404","article-title":"Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections","volume":"168","author":"Cattoretti","year":"1992","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.013_bib0027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jclinpath-2015-203174","article-title":"The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the ki-67 index","volume":"69","author":"Arima","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clbc.2025.05.013_bib0028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2017.07.041","article-title":"Interlaboratory variability of Ki67 staining in breast cancer","volume":"84","author":"Focke","year":"2017","journal-title":"Eur J Cancer (1965)"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.013_bib0029","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41598-024-51723-2","article-title":"AI improves accuracy, agreement and efficiency of pathologists for Ki67 assessments in breast cancer","volume":"14","author":"Dy","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.013_bib0030","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1002\/cjp2.346","article-title":"AI-based intra-tumor heterogeneity score of Ki67 expression as a prognostic marker for early-stage ER+\/HER2\u2212 breast cancer","volume":"10","author":"Lu","year":"2024","journal-title":"J Pathol Clin Res"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:58:05Z","timestamp":1763751485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1526820925001442"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.05.013","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor ki67 Impact on Survival in Male Breast Cancer Patients: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}